USE OF ACTIVATED-CHARCOAL TO REDUCE ELEVATED SERUM PHENOBARBITAL CONCENTRATION IN A NEONATE

被引:6
|
作者
VEERMAN, M
ESPEJO, MG
CHRISTOPHER, MA
KNIGHT, M
机构
[1] UNIV FLORIDA,COLL PHARM,DEPT PHARMACOL,GAINESVILLE,FL 32611
[2] UNIV FLORIDA,COLL MED,DEPT PEDIAT,DIV NEONATOL,GAINESVILLE,FL 32611
来源
关键词
PHENOBARBITAL; PHARMACOKINETICS; CHARCOAL; HUMAN; INFANT;
D O I
10.3109/15563659109038597
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The course of a neonate administered activated charcoal orally for elevated phenobarbital concentration is described. The neonate required a serum concentration of phenobarbital eventually exceeding 80-mu-g/mL for seizure control. However, due to the severe CNS injury as a result of the asphyxia at birth, a diagnosis of cerebral death by electroencephalogram and apnea test was pursued. This required the phenobarbital concentration to be less than 30-mu-g/mL. Serial phenobarbital concentrations during this time indicated a 250 hour half-life, which would require two weeks for the phenobarbital to drop below 30-mu-g/mL. With the administration of six doses of activated charcoal at 0.7 g/kg/dose, the phenobarbital serum concentration decreased to 22-mu-g/mL, giving an estimated phenobarbital half-life of 22 hours. This, and two other subsequent cases, indicates repeated doses of activated charcoal are effective in augmenting the clearance of certain drugs in the neonatal age group.
引用
收藏
页码:53 / 58
页数:6
相关论文
共 50 条